[Genetics, pain and analgesia].

Der Anaesthesist
Ulrike M StamerFrank Stuber

Abstract

Genomic variations influencing nociceptive sensitivity and susceptibility to pain conditions, as well as responses to pharmacotherapy of pain are currently under investigation. Candidate genes involved in pain perception, pain processing and pain management such as (opioid) receptors, transporters and other targets of pharmacotherapy are discussed. Drug metabolizing enzymes represent a further major target of ongoing research in order to identify associations between an individual's genetic profile and drug response (pharmacogenetics). Polymorphisms of the cytochrome P 450 enzymes influence analgesic efficacy of codeine, tramadol and tricyclic antidepressants (CYP2D6). Blood levels of some non-steroidal anti-inflammatory drugs (NSAIDs) are dependent on CYP2C9 activity, whereas opioid receptor polymorphisms are discussed with respect to differences in opioid-mediated analgesia and side-effects. Pharmacogenetics is seen as a potential diagnostic tool for improving patient therapy and care and will contribute to a more individualized drug treatment in the future.

References

Oct 1, 1995·Headache·B LarssonN L Pedersen
Feb 1, 1996·Acta Psychiatrica Scandinavica·U A MeyerA Delini-Stula
Dec 1, 1996·Clinical Pharmacology and Therapeutics·L PoulsenS H Sindrup
Apr 1, 1997·Clinical Pharmacology and Therapeutics·G MikusM Eichelbaum
Jan 1, 1997·European Journal of Clinical Pharmacology·W D PaarH J Dengler
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·C BondL Yu
Nov 30, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·D W Nebert
Feb 13, 2001·Acta Anaesthesiologica Scandinavica·T H Fagerlund, O Braaten
Nov 17, 2001·JAMA : the Journal of the American Medical Association·K A PhillipsW Sadee
Jun 1, 2002·Drugs & Aging·Edoardo Spina, Maria Gabriella Scordo
Jul 13, 2002·Arthritis and Rheumatism·Alan J HakimTim D Spector
Jan 22, 2003·British Journal of Clinical Pharmacology·Julia KirchheinerJürgen Brockmöller
Jan 25, 2003·Clinical Pharmacology and Therapeutics·Carsten SkarkeJörn Lötsch
Mar 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey S MogilRoger B Fillingim
Apr 17, 2003·European Journal of Clinical Pharmacology·Craig R LeeJoyce A Goldstein
May 8, 2003·European Journal of Clinical Pharmacology·Pedro DoradoAdrián LLerena
Aug 2, 2003·Pharmacogenetics·Julia KirchheinerJürgen Brockmöller
Sep 23, 2003·Pain·Ulrike M StamerFrank Stuber
Apr 13, 2004·Arthritis and Rheumatism·Alexander J MacGregorTim D Spector
Dec 31, 2004·The New England Journal of Medicine·Yvan GascheJules Desmeules
May 3, 2005·European Journal of Pain : EJP·Pilar ArmeroRogelio González-Sarmiento

❮ Previous
Next ❯

Citations

Nov 28, 2013·Der Anaesthesist·E M ZeidlerC Zöllner
Jun 11, 2011·Journal of Pain & Palliative Care Pharmacotherapy·Oliver H G Wilder-Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Pharmacotherapy
Ulrike M Stamer, Frank Stuber
Forensic Science International : Synergy
Maren Kleine-BrueggeneyUlrike M Stamer
Journal of Pharmacy Practice
Larisa H Cavallari
© 2022 Meta ULC. All rights reserved